Side-by-side financials for CRDF and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRDF | RVMD |
|---|---|---|
| Market cap | - | $32.71 B |
| US-listed rank | - | #439 |
| Revenue (latest FY) | $593.00K | $0.00 |
| Net income (latest FY) | -$45.85K | -$1.13B |
| Net margin | -7.7% | - |
| SEC filings | 1,000 | 782 |
In their latest fiscal years, Cardiff Oncology, Inc. reported $593.00K in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Cardiff Oncology, Inc. and Revolution Medicines, Inc., or browse the full rankings.